Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
about
Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1BMP7 expression correlates with secondary drug resistance in mantle cell lymphomaLoss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinomaInteractions between cells with distinct mutations in c-MYC and Pten in prostate cancer.Primer extension-based method for the generation of a siRNA/miRNA expression vector.Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-β receptor type I ALK5The Yin and Yang of bone morphogenetic proteins in cancer.Metastatic bone disease: role of transcription factors and future targets.Expression of BMP-7 in human gastric cancer and its clinical significance.Mesenchymal to epithelial transition in development and disease.miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation.The RUNX family in breast cancer: relationships with estrogen signaling.MAP Kinases and Prostate Cancer.MiR-135a functions as a selective killer of malignant glioma.Runx2 regulates survivin expression in prostate cancer cells.Lipopolysaccharide-induced apoptosis in transformed bovine brain endothelial cells and human dermal microvessel endothelial cells: the role of JNKIdentification of GRO1 as a critical determinant for mutant p53 gain of function.Tissue engineering a human phalanx.CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulationContextual effect of repression of bone morphogenetic protein activity in prostate cancer.Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.Recurrent copy number gains of ACVR1 and corresponding transcript overexpression are associated with survival in head and neck squamous cell carcinomas.
P2860
Q24337748-402626E4-29FF-4C14-9C60-9844E4CA88D3Q28533353-65E9B828-04AE-4F6B-B90B-0C273E87A859Q28535017-B47B4620-E39A-48DE-AE49-E474083C6DAFQ30866782-15D2F49A-7B96-4043-9E57-FFCE910D614FQ33297459-41C6EE13-9D33-49F3-8091-CCD1C6BEF888Q33622608-C8AC276A-70F2-4013-8107-0D5F3658E8CCQ33657811-824F6123-81CA-490A-B42E-58193D4DB233Q34127207-4FE1CB45-95DD-4DE5-B416-3CC788606DF2Q34217531-55BCC72C-490D-4B25-BBA4-0F5CEB5C05E0Q34627896-99DE96F9-0FCE-4B76-A654-369304328826Q36857740-21C56FDD-6A6C-42C2-85B5-22D978AE4865Q37620702-0CD5C7DC-0DFA-425E-9AE4-241F05FBDDF0Q38050410-219FAD4F-D6CD-435C-AAE9-E8B39B593877Q38791344-FACB5D82-328B-4EED-8FE1-DA997A9C785BQ39433440-917BE1AE-3B19-4433-B35D-4931DC3D413FQ39769098-3A71BD6F-08D9-4EE4-B743-4F1DF5A05A23Q39849367-97E278C6-63F5-4276-9FD0-B5466AA72186Q39877618-2FB39947-ADF2-41C6-9AE2-0C8F4DA9C68EQ39901632-BA5ADB29-268C-4E4A-BA6D-753BB2E3B6DEQ39963624-80873ABE-9B3E-4E34-97D9-826650EA7884Q41859712-7230DAAA-AE91-4654-9D55-049998B0507DQ41881214-C773DC2B-F6CC-4D49-8D08-DD20EC1FF8FAQ54582380-6E1C7D69-0959-4AD5-B696-FF62930445FB
P2860
Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Bone morphogenetic protein 7 p ...... NH2-terminal kinase pathways.
@en
type
label
Bone morphogenetic protein 7 p ...... NH2-terminal kinase pathways.
@en
prefLabel
Bone morphogenetic protein 7 p ...... NH2-terminal kinase pathways.
@en
P2093
P1433
P1476
Bone morphogenetic protein 7 p ...... NH2-terminal kinase pathways.
@en
P2093
A Hari Reddi
Dario C Altieri
Linda K Pham
Minyoung Lim
Pradip Roy-Burman
Shangxin Yang
Stephen E Kendall
P304
P356
10.1158/0008-5472.CAN-05-4456
P407
P577
2006-04-01T00:00:00Z